DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis

Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Allergic Conjunctivitis

Intervention: Olopatadine hydrochloride ophthalmic solution, 0.2% (Pataday®) (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Alcon Research


The purpose of this study is to evaluate patient perceptions of olopatadine 0. 2% dosed once daily in patients previously treated with twice-daily, topical, ocular, anti-allergy medications.

Clinical Details

Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Overall Patient Satisfaction

Overall Patient Satisfaction


Minimum age: 12 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- 12 years of age or older.

- History (within the past 24 months) of allergic conjunctivitis.

- Active signs and symptoms of ocular allergies.

- Ocular health within normal limits, as determined by the investigator or


- Willing to avoid contact lens wear each study visit immediately prior to study

medication instillation and for 10 minutes after instillation of study drug.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Contraindications or hypersensitivity to study medication or its components.

- One sighted eye or not correctable to 0. 6 logMAR or better in both eyes at the

screening visit.

- Known history of recurrent corneal erosion syndrome.

- Ocular trauma or surgical intervention within 6 months prior to Visit 1.

- Participation in any other investigational study within 30 days before Visit 1.

- Pregnant or nursing.

- Other protocol-defined exclusion criteria may apply.

Locations and Contacts

Additional Information

Starting date: June 2010
Last updated: March 5, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017